-
Recipharm Secures Vaccine Manufacturing Deal
contractpharma
January 28, 2022
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
-
Recipharm streamlines operations by selling oral solid dosage manufacturing site
CPhIonline
January 14, 2022
Astrea Pharma will be the new owner of the facility at Fontaine-lès-Dijon.
-
Pharmaron Acquires API Manufacturing Facility in UK from Recipharm
contractpharma
January 11, 2022
Continues to strengthen global chemistry and manufacturing capabilities and capacities.
-
Recipharm Sells Fontaine-lès-Dijon site to Astrea
contractpharma
January 11, 2022
Astrea is a newly established CDMO focused on small molecule oral solid and aseptic dosages.
-
Lyophilisation technology improving thermal stability and reducing cycle times, says Recipharm expert
CPhIonline
December 02, 2021
Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm.
-
Recipharm expands its analytical services offering in India
cphi-online
August 26, 2021
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions
-
Recipharm Invests in Fill Finish Capacity
contractpharma
July 19, 2021
New facility in Uttarakhand, India will increase capacity to 1 billion sterile units per year.
-
Recipharm to Build New Fill-Finish Facility in Morocco
contractpharma
July 07, 2021
Investment of around $500M by the Moroccan Government to establish capacity and capability for the manufacturing of vaccines and biotherapeutics.
-
Recipharm selected to operate new fill/finish facility in Morocco
cphi-online
July 07, 2021
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
-
Recipharm and Medspray Complete Joint Venture
contractpharma
February 09, 2021
Recipharm AB, a contract development and manufacturing organization (CDMO), and Medspray BV, a manufacturer of high tech spray nozzles, have completed a previously announced joint venture and established Resyca BV.